General Information
Drug ID
DR00623
Drug Name
Mefloquine
Synonyms
(+)-(11R,2'S)-erythro-Mefloquine; (+)-Mefloquine; (+)-Threo-Mefloquine; (-)-(11S,2'R)-erythro-Mefloquine; (-)-Mefloquine; (-)-Threo-Mefloquine; (DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol; Alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; Alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol; Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol; Lariam; Lariam (Hydrochloride); Lariam (TN); Mefaquin (TN); Mefloquin; Mefloquina; Mefloquina [INN-Spanish]; Mefloquine (USAN/INN); Mefloquine [USAN:INN:BAN]; Mefloquinone; Mefloquinum; Mefloquinum [INN-Latin]; Mephloquine; RO 13-7224; RO 13-7225; RTI1169-1-1; RTI1172-1-1; RTI1173-1-1; RTI1174-1-1; RTI1188-1-1; RTI1189-1-1; Racemic mefloquine; Ro 21-5998; Ro 21-5998 (Hydrochloride); Ro 215998; Ro-21-5998-001; SPB-80406; WR 142490; WR-142,490; WR-142490; WR-177,602; [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
Drug Type
Small molecular drug
Indication Malaria [ICD11: 1F40] Approved [1]
Therapeutic Class
Antimalarials
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=40692"></iframe>
3D MOL 2D MOL
Formula
C17H16F6N2O
Canonical SMILES
C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
InChI
InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1
InChIKey
XEEQGYMUWCZPDN-DOMZBBRYSA-N
CAS Number
CAS 53230-10-7
Pharmaceutical Properties Molecular Weight 378.318 Topological Polar Surface Area 45.2
Heavy Atom Count 26 Rotatable Bond Count 2
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 9
PubChem CID
40692
PubChem SID
103446060 , 104040016 , 104335053 , 124892361 , 135004437 , 135240375 , 135611150 , 135727482 , 137236385 , 140239432 , 14877790 , 175269604 , 178101069 , 179116766 , 223533437 , 223712526 , 226410988 , 243866056 , 252401319 , 252655885 , 26755467 , 29216385 , 34706437 , 47206659 , 49681220 , 50042965 , 50071333 , 51051233 , 53788688 , 56310966 , 56313823 , 57312460 , 603007 , 8176741 , 85154870 , 93166754 , 93167184 , 9835
ChEBI ID
CHEBI:63684
TTD Drug ID
D0GQ7K
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Doxycycline was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther. 2004 Jan;75(1):13-33.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.